Geschäft · 21.12.20111 Min. Lesezeit
Prospective Grant of Exclusive License: Veterinary Biological Products for Swine Influenza Vaccines
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the inventions embodied in Patent Applications USSN 61/021,596, filed Jan 16, 2008; 61/023,341, filed Jan 24, 2008; PCT/US2009/031329, filed Jan 16, 2009; and USSN 12/838,292, filed Jul 16, 2010; entitled "Influenza DNA Vaccination and Methods of Use Thereof", by Rao et al (NIAID/VRC) (E-050-2008/0,1,2,3), to Newport Laboratories having a place of business in 1520 Prairie Drive, Worthington, MN 56187. The patent rights in this invention have been assigned to the United States of America.